Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BALANCE
NCT07519395Phase 2Recruiting
- Sponsor
- GSK
- Start
- Apr 2026
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
A Phase 2 trial of camlipixant in irritable bowel syndrome (IBS), sponsored by GSK. Started Apr 2026; status: recruiting.
02
Drugs
camlipixant
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT07519395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07519395.